Management of kidney cancer patients: 2018 guidelines of the Italian Medical Oncology Association (AIOM)

In the past two decades, the treatment landscape for patients with metastatic renal cell carcinoma has significantly changed thanks to the approval of several targeted molecular therapies (VEGF and mTOR inhibitors) and recently immune-checkpoint inhibitors. The Italian Association of Medical Oncolog...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Tumori 2019-07, Vol.105 (4_suppl), p.3-12
Hauptverfasser: Giuseppa Vitale, Maria, Bracarda, Sergio, Cosmai, Laura, Crocetti, Emanuele, Di Lorenzo, Giuseppe, Lapini, Alberto, Mandressi, Alberto, Martorana, Giuseppe, Masini, Cristina, Montironi, Rodolfo, Ortega, Cinzia, Passalacqua, Rodolfo, Porta, Camillo, Procopio, Giuseppe, Sepe, Pierangela, Romano, Luigia, Luigi Pappagallo, Giovanni, Conti, Giario, Guida, Michele, Martignoni, Guido, Nolè, Franco, Pignata, Sandro, Gori, Stefania, Cartenì, Giacomo
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!